AdaptHealth Corp. Reports Q3 2024 Financial Results
AdaptHealth Corp. (NASDAQ: AHCO), a national leader in providing patient-centered healthcare-at-home solutions, reported its financial results for the third quarter. AdaptHealth specializes in home medical equipment, medical supplies, and the related services vital for patients' home care. This quarter signifies a continued commitment to enhancing patient outcomes while delivering robust financial performance.
Q3 Results and Highlights
Comparative analysis is based on results from the quarter that ended in the previous year.
- Net revenue for the quarter reached $805.9 million, slightly up from $804.0 million last year, marking an increase of 0.2%.
- Net income attributable to AdaptHealth was $22.9 million, a remarkable recovery from a net loss of $454.1 million in the same quarter last year.
- Adjusted EBITDA stood at $164.3 million, which is a 1.9% increase compared to $161.2 million in the prior year.
- Cash from operations surged to $391.4 million year-to-date, improving from $325.4 million during the same period last year. Free cash flow reached an impressive $162.7 million, up from $76.6 million.
- The quarter also saw the company successfully complete the sale of specific custom rehab assets, further streamlining operations.
Management Insights
Chief Executive Officer, Suzanne Foster, expressed optimism about future growth opportunities. "Our focus on assembling a high-performance team and investing strategically allows us to enhance our service to even more patients in their homes," she stated. Foster emphasized that the company is in a strong position to deliver effective solutions in a fast-evolving healthcare environment.
Updated Financial Outlook
AdaptHealth has updated its full-year guidance for 2024, reflecting the company’s positive trajectory:
- Net revenue estimates are now between $3.220 billion to $3.260 billion, revised from $3.255 billion to $3.315 billion.
- Adjusted EBITDA is expected to range from $655 million to $675 million, down from the prior estimate of $660 million to $700 million.
- Free cash flow is now anticipated between $175 million to $195 million, compared to the previous forecast of $160 million to $180 million.
Conference Call Information
Management is hosting a teleconference to discuss these results and ongoing initiatives. Interested participants may join the call by dialing:
- Domestic: (800) 343-4136
- International: (203) 518-9843
For the teleconference, please reference Conference ID: AHCO3Q24.
About AdaptHealth Corp.
AdaptHealth stands at the forefront of the healthcare-at-home sector, offering a comprehensive suite of solutions. These include products for managing chronic conditions and enhancing the quality of life for patients. With partnerships across a wide range of healthcare providers, the company serves approximately 4.2 million patients annually through its extensive network of around 670 locations.
Frequently Asked Questions
What key highlights were reported for Q3 2024?
AdaptHealth reported a net revenue of $805.9 million and a net income of $22.9 million, showcasing strong financial recovery.
How has AdaptHealth's financial outlook changed for 2024?
The company updated its guidance, now predicting a net revenue between $3.220 billion to $3.260 billion.
What were the significant changes in cash flow?
Cash flow from operations increased to $391.4 million, with free cash flow reaching $162.7 million.
What is the focus of management moving forward?
Management is committed to pursuing growth opportunities and enhancing patient care through strategic investments and team building.
How does AdaptHealth define Adjusted EBITDA?
Adjusted EBITDA is calculated by adding specific non-recurring expenses and changes in liabilities to standard EBITDA figures.
